Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas

Journal of Gastrointestinal Surgery

Volumn 13, Issue 1, 2009, Pages 85-92

  Murakami, Yoshiaki ^a   Uemura, Kenichiro ^a   Sudo, Takeshi ^a   Hayashidani, Yasuo ^a   Hashimoto, Yasushi ^a   Ohge, Hiroki ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Gemcitabine; Pancreatic adenocarcinoma of the body or tail; Postoperative adjuvant chemotherapy; Prognostic factor; S 1

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; OXONIC ACID; RIBONUCLEOTIDE REDUCTASE; S 1 (COMBINATION); TEGAFUR;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PANCREAS RESECTION; PANCREAS TUMOR; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXONIC ACID; PANCREATECTOMY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; RIBONUCLEOTIDE REDUCTASES; TEGAFUR; TREATMENT OUTCOME;

EID: 57849164479     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0650-4     Document Type: Article

References (31)

1. Y Murakami K Uemura T Sudo Y Hayashidani Y Hashimoto H Ohge 2008 Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma J Gastrointest Surg 12 534 541
2. S Takai S Satoi H Toyokawa H Yanagimoto N Sugimoto K Tsuji 2003 Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: A retrospective, single-institution experience Pancreas 26 243 249
3. M Tani M Kawai H Terasawa S Ina S Hirono K Uchiyama 2006 Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer? J Surg Oncol 93 485 490
4. A Nakao A Harada T Nonami T Kaneko H Takagi 1996 Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer Pancreas 12 357 361
5. M Wagner C Redaelli M Lietz CA Seiler H Friess MW Büchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586 594
6. P Magistrelli A Antinori A Crucitti A La Greca R Masetti R Coppola 2000 Prognostic factors after surgical resection for pancreatic carcinoma J Surg Oncol 74 36 40
7. KM Brown C Domin GV Aranha S Yong M Shoup 2005 Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas Am J Surg 189 278 282
8. C Gebhardt W Meyer M Reichel PH Wunsch 2000 Prognostic factors in the operative treatment of ductal pancreatic carcinoma Langenbecks Arch Surg 385 14 20
9. AC Berger IM Meszoely EA Ross JC Watson JP Hoffman 2004 Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma Ann Surg Oncol 11 644 649
10. CR Ferrone DM Finkelstein SP Thayer A Muzikansky C Fernandez-delCastillo AL Warshaw 2006 Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma J Clin Oncol 24 2897 2902
11. M Shoup KC Conlon D Klimstra MF Brennan 2003 Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg 7 946 952
12. C Sperti C Pasquali S Pedrazzoli 1997 Ductal adenocarcinoma of the body and tail of the pancreas J Am Coll Surg 185 255 259
13. MF Brennan RD Moccia D Klimstra 1996 Management of adenocarcinoma of the body and tail of the pancreas Ann Surg 223 506 511
14. K Shimada Y Sakamoto T Sano T Kosuge 2006 Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail Surgery 139 288 295
15. TA Sohn CJ Yeo JL Cameron L Koniaris S Kaushal RA Abrams 2000 Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators J Gastrointest Surg 4 567 579
16. H Ozaki T Kinoshita T Kosuge J Yamamoto K Shimada K Inoue 1996 An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas Cancer 77 2240 2245
17. A Nakao A Harada T Nonami T Kaneko S Nomoto H Koyama 1997 Lymph node metastasis in carcinoma of the body and tail of the pancreas Br J Surg 84 1090 1092
18. JD Christein ML Kendrick CW Iqbal DM Nagorney MB Farnell 2005 Distal pancreatectomy for resectable adenocarcinoma of the body and tail of the pancreas J Gastrointest Surg 9 922 927
19. SM Strasberg DC Linehan WG Hawkins 2007 Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: Ability to obtain negative tangential margins J Am Coll Surg 204 244 249
20. S Hirano S Kondo T Hara Y Ambo E Tanaka T Shichinohe 2007 Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: Long-term results Ann Surg 246 46 51
21. T Shirasaka Y Shimamato H Ohshimo M Yamaguchi T Kato K Yonekura 1996 Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators Anticancer Drugs 7 548 557
22. M Tsujie S Nakamori S Nakahira S Takeda Y Takahashi N Hayashi 2006 Schedule-dependent therapeutic effects of gemcitabine combined with Uracil-Tegafur in a human pancreatic cancer xenograft model Pancreas 33 142 147
23. K Nakamura T Yamaguchi T Ishihara K Sudo H Kato H Saisho 2006 Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer Br J Cancer 94 1575 1579
24. Y Murakami K Uemura T Sudo Y Hayashidani Y Hashimoto N Nakagawa 2008 Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma Am J Surg 195 757 762
25. Y Murakami K Uemura H Ohge Y Hayashidani T Sudo T Sueda 2006 Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma Surgery 140 448 453
26. Y Murakami K Uemura Y Hayashidani T Sudo T Sueda 2007 Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas J Gastrointest Surg 11 338 344
27. International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002.
28. JP Neoptolemos DD Stocken H Friess C Bassi JA Dunn H Hickey European Study Group for Pancreatic Cancer 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 1200 1210
29. H Oettle S Post P Neuhaus K Gellert J Langrehr K Ridwelski 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 267 277
30. DD Stocken MW Buchler C Dervenis C Bassi H Jeekel JH Klinkenbijl Pancreatic Cancer Meta-analysis Group 2005 Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 1372 1381
31. Y Murakami K Uemura T Sasaki Y Hayashidani T Sudo T Sueda 2005 Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juice Surgery 138 962 963